Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells

The histone demethylase LSD1 (KDM1A) demethylates mono- and di-methylated (Me2) lysine (K) 4 on histone H3. High LSD1 expression blocks differentiation and confers a poor prognosis in AML. Here, treatment with the novel LSD1 antagonist SP2509 attenuated the binding of LSD1 with the co-repressor CoRE...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Leukemia
Huvudupphovsmän: Fiskus, Warren, Sharma, Sunil, Shah, Bhavin, Portier, Bryce P., Devaraj, Santhana G. T., Liu, Ka, Iyer, Swaminathan P., Bearss, David, Bhalla, Kapil N.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2014
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4739780/
https://ncbi.nlm.nih.gov/pubmed/24699304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2014.119
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk